Phares AG, located in Basel, Switzerland provides a range of services and products to develop dosage forms for insoluble compounds. Phares 360 services (www.Phares360.com) include pharmaceutical...
Article - 7 Oct 2009
Liposome is attracting attention as a drug carrier for chemotherapeutic agents because of its ability to easily regulate lipid composition, particle diameter, charge, etc., and the ability to...
Article - 26 Mar 2004
A new method for producing uniform, self-assembled nanocells has been developed by researchers at the National Institute of Standards and Technology (NIST). Posted March 11 2004
Article - 18 Apr 2005
Using a Malvern Panalytical Zetasizer 3000HS, it has been show that the mixed mode measurement of the wall zeta potential is a novel way to follow both the kinetics and equilibrium adsorption of the...
Article - 12 Apr 2005
Advances in medical nanotechnology are likely to be used in biomedical applications for space projects. This article looks at medical diagnostics, biochips, lab on a chip systems, medical sensors,...
Article - 10 Dec 2004
There are several different methods of classification for nanomaterials according to dimension, phase composition and the manufacturing process. This article focuses on the categorisation of...
Article - 13 Apr 2015
Soft materials such as micelles and liposomes hold promise in the pharmaceutical sector as drug delivery vehicles. As the interest in accurate drug delivery is increasing, these microemulsions need to...
Article - 2 May 2005
The surface characteristics of steric stabilized liposomes are determined by both the molecular mass of the PEG and the amount of the PEG derivatized phospholipid incorporated into the lipid bilayer....
Article - 6 May 2005
The physical characterization of liposomes is of great importance in understanding their suitability for a range of applications. Knowledge of the zeta potential of a liposome preparation can help to...
Article - 12 May 2005
Much work is being done in the development of vectors containing specific molecules. Liposomal systems containing certain cell surface receptor-specific peptides are being developed.